ROCK1 and metastatic melanoma: We found that, after passage through the first challenge, WM983B, but not WM983A, cells displayed higher MLC2 activity (Fig. 1k), suggesting that passage through the first constraint activates a Rho-ROCK1/2-dependent migration programme specifically in metastatic melanoma cells.